uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Histological characterization of orphan transporter MCT14 (SLC16A14) shows abundant expression in mouse CNS and kidney
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Functional Pharmacology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Functional Pharmacology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Functional Pharmacology.
Show others and affiliations
2016 (English)In: BMC neuroscience (Online), ISSN 1471-2202, E-ISSN 1471-2202, Vol. 17, 43Article in journal (Refereed) Published
Abstract [en]

Background: MCT14 (SLC16A14) is an orphan member of the monocarboxylate transporter (MCT) family, also known as the SLC16 family of secondary active transmembrane transporters. Available expression data for this transporter is limited, and in this paper we aim to characterize MCT14 with respect to tissue distribution and cellular localization in mouse brain. Results: Using qPCR, we found that Slc16a14 mRNA was highly abundant in mouse kidney and moderately in central nervous system, testis, uterus and liver. Using immunohistochemistry and in situ hybridization, we determined that MCT14 was highly expressed in excitatory and inhibitory neurons as well as epithelial cells in the mouse brain. The expression was exclusively localized to the soma of neurons. Furthermore, we showed with our phylogenetic analysis that MCT14 most closely relate to the aromatic amino acid- and thyroid-hormone transporters MCT8 (SLC16A2) and MCT10 (SLC16A10), in addition to the carnitine transporter MCT9 (SLC16A9). Conclusions: We provide here the first histological mapping of MCT14 in the brain and our data are consistent with the hypothesis that MCT14 is a neuronal aromatic-amino-acid transporter.

Place, publisher, year, edition, pages
2016. Vol. 17, 43
Keyword [en]
Monocarboxylate; Transporter; Mouse; Amino acid
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-282951DOI: 10.1186/s12868-016-0274-7ISI: 000379823100001PubMedID: 27364523OAI: oai:DiVA.org:uu-282951DiVA: diva2:918111
Funder
Swedish Research CouncilThe Swedish Brain FoundationSwedish Society for Medical Research (SSMF)Novo Nordisk
Available from: 2016-04-10 Created: 2016-04-08 Last updated: 2017-11-30Bibliographically approved
In thesis
1. Characterization of Centrally Expressed Solute Carriers: Histological and Functional Studies with Transgenic Mice
Open this publication in new window or tab >>Characterization of Centrally Expressed Solute Carriers: Histological and Functional Studies with Transgenic Mice
2016 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[en]
: His
Abstract [en]

The Solute Carrier (SLC) superfamily is the largest group of membrane-bound transporters, currently with 456 transporters in 52 families. Much remains unknown about the tissue distribution and function of many of these transporters. The aim of this thesis was to characterize select SLCs with emphasis on tissue distribution, cellular localization, and function.       In paper I, we studied the leucine transporter B0AT2 (Slc6a15). Localization of B0AT2 and Slc6a15 in mouse brain was determined using in situ hybridization (ISH) and immunohistochemistry (IHC), localizing it to neurons, epithelial cells, and astrocytes. Furthermore, we observed a lower reduction of food intake in Slc6a15 knockout mice (KO) upon intraperitoneal injections with leucine, suggesting B0AT2 is involved in mediating the anorexigenic effects of leucine.     In paper II, we studied the postnatal, forebrain-specific deletion of Slcz1, belonging to the SLC18 family, in conditional KO mice (cKO). We observed a decreased response to diazepam and a higher neuronal activity in cortex and hippocampus of cKO mice, as well as an impairment in short-term recognition memory. Intracellular expression was found in neurons but not astrocytes with IHC, indicating SLCZ1 is implicated in neuronal regulation of locomotion and memory.    In paper III, we performed the first detailed histological analysis of PAT4, a transporter belonging to the SLC36 family, involved in the activation of mTOR complex 1 on lysosomes. We found abundant Slc36a4 mRNA and PAT4 expression in mouse brain, using ISH and IHC. We used IHC to localize PAT4 to both inhibitory and excitatory neurons and epithelial cells. We also found both intracellular- and plasmalemmal expression and partial colocalization of PAT4 with lysosomal markers.    Lastly, in paper IV, we provided the first tissue mapping of orphan transporter MCT14 (SLC16A14). Using qPCR, we detected moderate to high Slc16a14 mRNA in the central nervous system and kidney. We found widespread Slc16a14 and MCT14 in mouse brain using ISH and IHC. We also found MCT14 to have intracellular and plasmalemmal expression in mainly excitatory but also inhibitory neurons, as well as epithelial cells. We found MCT14 to be most closely related to MCT8, MCT2 and MCT9, suggesting a similar role for this transporter.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2016. 62 p.
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 1215
Keyword
SLC, Solute carriers, Amino acid transporter, PAT, B0AT2, mTORC1
National Category
Neurosciences
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-282956 (URN)978-91-554-9555-8 (ISBN)
Public defence
2016-06-03, B:21, Husargatan. 75124 Uppsala, Uppsala, 13:15 (English)
Opponent
Supervisors
Available from: 2016-05-12 Created: 2016-04-08 Last updated: 2016-06-01

Open Access in DiVA

fulltext(5309 kB)77 downloads
File information
File name FULLTEXT01.pdfFile size 5309 kBChecksum SHA-512
19b77e7a731babce6e5ace2c6322306ed81f0fbb3961694a9fdaba63dcf202b5ffd2809cc4894fba7f730d1cb227709efb50caeeb4c50688c8ce142cfa845123
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Roshanbin, SaharLekholm, EmiliaPerland, EmelieEriksson, MikaelaRaine, AmandaFredriksson, Robert

Search in DiVA

By author/editor
Roshanbin, SaharLekholm, EmiliaPerland, EmelieEriksson, MikaelaRaine, AmandaFredriksson, Robert
By organisation
Functional PharmacologyDepartment of Pharmaceutical BiosciencesMolecular Medicine
In the same journal
BMC neuroscience (Online)
Neurology

Search outside of DiVA

GoogleGoogle Scholar
Total: 77 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 304 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf